Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Anti-tumor effects of rivoceranib against canine melanoma and mammary gland tumour in vitro and in vivo mouse xenograft models

Fig. 2

Effects of rivoceranib on cell cycle arrest in vitro. A Cell cycle distribution of LMeC and CHMp cells treated with rivoceranib was analysed by flow cytometry at 48 h. B The expression levels of cyclin-D1 were measured using western blot analysis. The intensity of the band on the films is presented as the relative ratio of cyclin-D1 to the band intensity of β-actin. Cropped blots are displayed. Samples were derived from same experiment, and blots were processed in parallel. The data represent the mean ± standard deviation obtained from three independent experiments. * p < 0.05, ** p < 0.01

Back to article page